S Slavin

Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation

S Slavin, E Naparstek, A Nagler et al. · Blood · 1996 · 418 citations

Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation

Mohamad Mohty, Myriam Labopin, Reza Tabrizzi et al. · Haematologica · 2008 · 103 citations · Full text

Retrospective Study, Cell Therapy, Leukemia-free Survival +14

Inhibition of Collagen Synthesis and Changes in Skin Morphology in Murine Graft-Versus-Host Disease and Tight Skin Mice: Effect of Halofuginone

Francesca Levi‐Schaffer, Arnon Nagler, S Slavin et al. · Journal of Investigative Dermatology · 1996 · 75 citations · Full text

Inflammation, Tissue Engineering, Xenotransplantation +12

Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.

Lola Weiss, Ido Lubin, I Factorowich et al. · The Journal of Immunology · 1994 · 67 citations

Potential use of interleukin-6 in bone marrow transplantation: effects of recombinant human interleukin-6 after syngeneic and semiallogeneic bone marrow transplantation in mice

T Givon, M Revel, S Slavin · Blood · 1994 · 25 citations · Full text